State Tipoffs Involving Missouri Newsletter for Friday November 15, 2024 ( 4 items ) |
Evangel University Theology Professor's Latest Book Highlights Decades of Research Into Luke & Acts
SPRINGFIELD, Missouri, Nov. 15 (TNSres) -- Evangel University issued the following news release:
Dr. Martin Mittelstadt, professor of New Testament Theology at Evangel University, recently released his latest book, "The Evolution of a Pentecostal Scholar: Twenty Years in Luke-Acts," which includes a collection of previously published essays and fresh reflections highlighting more than two decades of academic engagement with Luke-Acts.
Mittelstadt, a Winnipeg, Canada native, began his professor
more
Former SEC Lawyer Joins BCLP's Litigation & Investigations Practice
ST. LOUIS, Missouri, Nov. 15 -- Bryan Cave Leighton Paisner, a law firm, issued the following news on Nov. 14, 2024:
International law firm BCLP announced today the addition of Partner Josh Hess to the firm's Financial Disputes and Investigations practice. Josh joins the firm's Atlanta office.
Formerly with the Securities and Exchange Commission (SEC)'s Enforcement Division, Josh focuses his practice on securities enforcement, regulatory investigations, and complex commercial litigation. With
more
New Partner Boosts BCLP's Energy, Environment, and Infrastructure Team
ST. LOUIS, Missouri, Nov. 15 -- Bryan Cave Leighton Paisner, a law firm, issued the following news on Nov. 14, 2024:
International law firm BCLP announced today the addition of Partner Matt Sides to the firm's Energy, Environment, and Infrastructure practice group and our Energy Transition Sector -- a priority sector for the firm. Matt joins the firm's Charlotte office.
Matt focuses his practice on advising lenders, tax equity investors, and sponsors on the financing, acquisition, development,
more
Washington University School of Medicine: Vaccine Shows Promise Against Aggressive Breast Cancer
ST. LOUIS, Missouri, Nov. 15 (TNSres) -- The Washington University School of Medicine issued the following news release:
* * *
Clinical trial targeted recurrence of hard-to-treat triple-negative breast cancer
* * *
A small clinical trial shows promising results for patients with triple-negative breast cancer who received an investigational vaccine designed to prevent recurrence of tumors. Conducted at Washington University School of Medicine in St. Louis with a therapy designed by WashU Medi
more
|
Sign up to Receive this newsletter every day via email.